A North Yorkshire hospital has introduced AI technology that could speed up the detection of lung cancer and other serious illnesses. Harrogate and District NHS Foundation Trust said the software would "significantly improve" the efficiency and accuracy of chest X-ray analysis.

The MASAI trial reveals AI in mammography increases cancer detection by 29% and decreases radiologists' workload by 44%, ensuring diagnostic reliability.

New research results now published from Lund University's MASAI trial are even better than the initial findings from last year: AI-supported breast screening detected 29% more cases of cancer compared with traditional screening.

Nearly 700,000 women are to be recruited to take part in an NHS artificial intelligence (AI) breast cancer screening trial in England.Five different AI platforms will be tested across 30 sites from April to see if the technology can speed up diagnosis as well as free up radiologists.

Julia Bradbury believes new AI breast cancer screening could have detected disease earlierGood Morning Britain

AI tools like the ones being tested in the EDITH trial could help facilitate the screening process, allowing the NHS to manage its resources better. With around 2.1 million mammogram screenings carried out annually, AI could significantly reduce the time required for each screening, making the system more efficient.

The NHS is launching the world's largest artificial intelligence trial for breast cancer detection - which is set to analyse hundreds of thousands of mammograms across England. The groundbreaking study will examine at least 700,

The NHS is launching the world's biggest trial of AI to detect breast cancer, screening two-thirds of 700,000 women. Five different types of AI will read about 462,000 mammograms at 30 breast cancer screenings later.